5 completed, 1 withdrawn. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Crinone: new trials by email Literature Review of Crinone trials Research Report on Crinone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. Progesterone-IBSA Injectable Solution, Progesterone Vaginal Gel with Applicator, Placebo Vaginal gel with applicator - Infertility | Phase 3 | Completed | IBSA Institut Biochimique SA | 688 | 2022-10-12 | 2026-08-27 |
| A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II) Dydrogesterone 30 mg, intravaginal progesterone gel 90 mg - Female Infertility | Phase 3 | Completed | Abbott | 1034 | 2015-07-01 | 2019-10-01 |
| An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) MK-8962, recFSH, Ganirelix - Infertility | Phase 3 | Withdrawn | Organon and Co | 2014-03-01 | 2022-02-03 | |
| Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole Progesterone Vaginal Gel 8%, Letrozole Oral Tablet, pelvic ultrasound - Polycystic Ovary Syndrome | Phase 2 / Phase 3 | Completed | Eastern Virginia Medical School | 52 | 2012-07-06 | 2018-02-26 |
| Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) Endometrin, Crinone - Fertility | Phase 3 | Completed | Ferring Pharmaceuticals | 1211 | 2005-07-01 | 2011-05-19 |
| Vaginal Progesterone to Reduce the Risk of Another Preterm Birth 8% progesterone vaginal gel, Placebo Vaginal Gel - Pregnancy | Phase 3 | Completed | Juniper Pharmaceuticals, Inc. | 636 | 2004-04-01 | 2010-08-19 |
Infertility (2) · Infertility, Female (1) · Polycystic Ovary Syndrome (1)
Abbott (1) · Eastern Virginia Medical School (1) · Ferring Pharmaceuticals (1) · IBSA Institut Biochimique SA (1) · Juniper Pharmaceuticals, Inc. (1) · Organon and Co (1)
United States (3) · Australia (1) · Belgium (1) · China (1) · Germany (1) · Hong Kong (1) · India (1) · Russia (1) · Singapore (1) · Thailand (1) · Ukraine (1)
George W Creasy, MD (1) · Laurel A Stadtmauer, MD, PhD (1) · Shreyansh Shah, MD (1)